menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

FDA: Addressing Concerns About Marketing Unapproved Drugs

close
FDA: Addressing Concerns About Marketing Unapproved Drugs
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    The Federal Food, Drug and Cosmetic Act generally requires drugs to be both safe and effective prior to marketing and widespread use.  But, despite this act, not all marketed drugs have undergone FDA approval. Dr. Jason Woo, associate director for Scientific and Medical Affairs in the Office of Compliance for the Center for Drug Evaluation and Research, discusses measures the FDA has undertaken to address the issue of these drugs on the market. Hosted by Dr. Charles Turck.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    The Federal Food, Drug and Cosmetic Act generally requires drugs to be both safe and effective prior to marketing and widespread use.  But, despite this act, not all marketed drugs have undergone FDA approval. Dr. Jason Woo, associate director for Scientific and Medical Affairs in the Office of Compliance for the Center for Drug Evaluation and Research, discusses measures the FDA has undertaken to address the issue of these drugs on the market. Hosted by Dr. Charles Turck.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 11/23/20